Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.60 |
| ▸ | KAT2B | Q92831 | 9/20 | 0.59 |
| ▸ | EP300 | Q09472 | 5/20 | 0.58 |
| ▸ | MGLL | Q99685 | 2/20 | 0.47 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | G6PD | P11413 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1956520 | 0.79 | KAT2B (0.65) | IDO1KAT2BEP300MGLLPIN1 | |
| SCHEMBL9320095 | 0.76 | IDO1 (1.00) | IDO1KAT2BEP300ALDH1A1HPGD | |
| SCHEMBL7624622 | 0.75 | KAT2B (0.64) | IDO1KAT2BEP300MGLLPIN1 | |
| SCHEMBL9132689 | 0.74 | ALDH1A1 (0.68) | IDO1KAT2BMGLLALDH1A1HPGD | |
| SCHEMBL22657 | 0.74 | KAT2B (1.00) | IDO1KAT2BEP300PIN1ALDH1A1 | |
| SCHEMBL1899386 | 0.73 | IDO1 (0.71) | IDO1KAT2BEP300ALDH1A1HPGD | |
| SCHEMBL81082 | 0.69 | KAT2B (0.59) | IDO1KAT2BEP300PIN1ALDH1A1 | |
| SCHEMBL9130886 | 0.67 | KAT2B (0.73) | IDO1KAT2BEP300PIN1MAPT | |
| SCHEMBL112959 | 0.64 | MGLL (1.00) | MGLLALDH1A1HPGDTDP1HSP90AA1 | |
| SCHEMBL14490265 | 0.64 | MGLL (0.48) | MGLLALDH1A1HPGDKDM4ECYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090027774-A1 | COMPOSITION FOR ANISOTROPIC DYESTUFF FILM, ANISOTROPIC DYESTUFF FILM AND POLARIZING ELEMENT | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-01-29 | — | — | US | claimed |
| EP-1860469-A1 | COMPOSITION FOR ANISOTROPIC DYESTUFF FILM, ANISOTROPIC DYESTUFF FILM AND POLARIZING ELEMENT | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-11-28 | — | — | EP | claimed |
| US-9011988-B2 | Liquid-crystal compound, liquid-crystal composition, light absorption anisotropic film, and liquid-crystal display device | FUJIFILM CORPORATION (JP) | 2015-04-21 | — | — | US | disclosed |
| US-8927070-B2 | Dichroic dye composition, light absorption anisotropic film, and polarizing element | FUJIFILM CORPORATION (JP) | 2015-01-06 | — | — | US | disclosed |
| US-8623476-B2 | Polarizing element and method of producing the same | FUJIFILM CORPORATION (JP) | 2014-01-07 | — | — | US | disclosed |
| US-8541935-B2 | Color filter and light-emitting display element | UDC IRELAND LIMITED (IE) | 2013-09-24 | — | — | US | disclosed |
| US-8518957-B2 | Methanocarba adenosine derivatives, pharmaceutical compositions, and method of reducing intraocular pressure | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2013-08-27 | — | — | US | disclosed |
| US-8518957-B2 | Methanocarba adenosine derivatives, pharmaceutical compositions, and method of reducing intraocular pressure | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2013-08-27 | — | — | US | disclosed |
| US-20130187090-A1 | LIQUID-CRYSTAL COMPOUND, LIQUID-CRYSTAL COMPOSITION, LIGHT ABSORPTION ANISOTROPIC FILM, AND LIQUID-CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2013-07-25 | — | — | US | disclosed |
| EP-2554536-A1 | LIQUID CRYSTALLINE COMPOUND, LIQUID CRYSTALLINE COMPOSITION, ANISOTROPICALLY LIGHT-ABSORBING FILM, AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM Corporation (JP) | 2013-02-06 | — | — | EP | disclosed |
| US-20120264769-A1 | METHANOCARBA ADENOSINE DERIVATIVES AND DENDRIMER CONJUGATES THEREOF | The United States of Americia, as represented by the Secretary, Department of Health and Human Serv (US) | 2012-10-18 | — | — | US | disclosed |
| US-20120264769-A1 | METHANOCARBA ADENOSINE DERIVATIVES AND DENDRIMER CONJUGATES THEREOF | The United States of Americia, as represented by the Secretary, Department of Health and Human Serv (US) | 2012-10-18 | — | — | US | disclosed |
| US-20120099054-A1 | COLOR FILTER AND LIGHT-EMITTING DISPLAY ELEMENT | UDC IRELAND LIMITED (IE) | 2012-04-26 | — | — | US | disclosed |
| US-20110177315-A1 | DICHROIC DYE COMPOSITION, LIGHT ABSORPTION ANISOTROPIC FILM, AND POLARIZING ELEMENT | FUJIFILM CORPORATION (JP) | 2011-07-21 | — | — | US | disclosed |
| US-20100134726-A1 | POLARIZING ELEMENT AND METHOD OF PRODUCING THE SAME | FUJIFILM CORPORATION (JP) | 2010-06-03 | — | — | US | disclosed |
| US-20090274853-A1 | DICHROIC DYE COMPOSITION | FUJIFILM CORPORATION (JP) | 2009-11-05 | — | — | US | disclosed |
| US-20090027774-A1 | COMPOSITION FOR ANISOTROPIC DYESTUFF FILM, ANISOTROPIC DYESTUFF FILM AND POLARIZING ELEMENT | MITSUBISHI CHEMICAL CORPORATION (JP) | 2009-01-29 | — | — | US | disclosed |
| EP-1860469-A1 | COMPOSITION FOR ANISOTROPIC DYESTUFF FILM, ANISOTROPIC DYESTUFF FILM AND POLARIZING ELEMENT | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-11-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090274853-A1 | DICHROIC DYE COMPOSITION | C1S, CDY1; CDY1B, CRY1 | IDO1 256/4885KAT2B 1623/4885EP300 1091/4885 |
| US-20120264769-A1 | METHANOCARBA ADENOSINE DERIVATIVES AND DENDRIMER CONJUGATES THEREOF | ADORA3, ADORA2A, ADORA1 | IDO1 3423/4885KAT2B 4655/4885EP300 4729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.